征募
发表于 2025-3-21 16:49:11
书目名称Quantity Surveying Practice影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0781021<br><br> <br><br>书目名称Quantity Surveying Practice影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0781021<br><br> <br><br>书目名称Quantity Surveying Practice网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0781021<br><br> <br><br>书目名称Quantity Surveying Practice网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0781021<br><br> <br><br>书目名称Quantity Surveying Practice被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0781021<br><br> <br><br>书目名称Quantity Surveying Practice被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0781021<br><br> <br><br>书目名称Quantity Surveying Practice年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0781021<br><br> <br><br>书目名称Quantity Surveying Practice年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0781021<br><br> <br><br>书目名称Quantity Surveying Practice读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0781021<br><br> <br><br>书目名称Quantity Surveying Practice读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0781021<br><br> <br><br>
门闩
发表于 2025-3-21 22:49:36
Ivor H. Seeley BSc (Est Man), MA, PhD, FRICS, CEng, FICE, FCIOB, FCIH pharmacological testing of the selected compound in high doses in tests directed at indications other than the intended indication of the new compound. These tests were followed by pharmacokinetic studies, which were mainly aimed at confirming of a suitable half-life time and at oral activity. Safe
larder
发表于 2025-3-22 02:32:29
Ivor H. Seeley BSc (Est Man), MA, PhD, FRICS, CEng, FICE, FCIOB, FCIH pharmacological testing of the selected compound in high doses in tests directed at indications other than the intended indication of the new compound. These tests were followed by pharmacokinetic studies, which were mainly aimed at confirming of a suitable half-life time and at oral activity. Safe
知识分子
发表于 2025-3-22 05:45:38
Ivor H. Seeley BSc (Est Man), MA, PhD, FRICS, CEng, FICE, FCIOB, FCIH in drug finding, drug development and decision making in th.Safety aspects have become an outstanding issue in the process of drug discovery and development. Until 15 years ago safety aspects were addressed by pharmacological testing of the selected compound in high doses in tests directed at indic
Brittle
发表于 2025-3-22 09:52:43
http://reply.papertrans.cn/79/7811/781021/781021_5.png
下级
发表于 2025-3-22 16:52:15
Ivor H. Seeley BSc (Est Man), MA, PhD, FRICS, CEng, FICE, FCIOB, FCIH in drug finding, drug development and decision making in th.Safety aspects have become an outstanding issue in the process of drug discovery and development. Until 15 years ago safety aspects were addressed by pharmacological testing of the selected compound in high doses in tests directed at indic
组成
发表于 2025-3-22 18:10:26
http://reply.papertrans.cn/79/7811/781021/781021_7.png
任命
发表于 2025-3-22 21:27:29
Ivor H. Seeley BSc (Est Man), MA, PhD, FRICS, CEng, FICE, FCIOB, FCIH pharmacological testing of the selected compound in high doses in tests directed at indications other than the intended indication of the new compound. These tests were followed by pharmacokinetic studies, which were mainly aimed at confirming of a suitable half-life time and at oral activity. Safe
commune
发表于 2025-3-23 05:23:43
http://reply.papertrans.cn/79/7811/781021/781021_9.png
Substance-Abuse
发表于 2025-3-23 07:13:02
http://reply.papertrans.cn/79/7811/781021/781021_10.png